Effect of clinical pharmacy services on patient safety, treatment perception and adherence in patients with acute lymphoblastic leukemia
Phase 3
- Conditions
- Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]
- Registration Number
- CTRI/2022/10/046780
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed with acute Lymphoblastic Leukemia
Exclusion Criteria
Patients with MMSE score less than 23 with history of cognitive deficiency
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method